Literature DB >> 10556651

Process of carboxylation of glutamic acid residues in the gla domain of human des-gamma-carboxyprothrombin.

S Uehara1, K Gotoh, H Handa, K Honjo, A Hirayama.   

Abstract

In the absence of vitamin K (VK) or in the presence of VK antagonists, hepatic VK-dependent carboxylase activity is inhibited and des-gamma-carboxyprothrombin (DCP) is released into the blood. We analyzed the number of glutamic acid (Glu) residues and their positions in the Gla domain (GD) of DCP to investigate the gamma-carboxylation mechanism of VK-dependent carboxylase. Several DCPs were found in each subject studied. The 10 Gla residues of human prothrombin were carboxylated in order from the N-terminal (residues 26, 25, 16, 29, 20, 19, 14, 32, 7 and 6). The process of Glu carboxylation seemed to proceed three-dimensionally from inside to outside the molecule.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10556651     DOI: 10.1016/s0009-8981(99)00152-7

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  7 in total

Review 1.  Molecular Pathways and Roles for Vitamin K2-7 as a Health-Beneficial Nutraceutical: Challenges and Opportunities.

Authors:  Nikita Jadhav; Saiprasad Ajgaonkar; Praful Saha; Pranay Gurav; Amitkumar Pandey; Vivek Basudkar; Yash Gada; Sangita Panda; Shashank Jadhav; Dilip Mehta; Sujit Nair
Journal:  Front Pharmacol       Date:  2022-06-14       Impact factor: 5.988

2.  Exon 2 deletion splice variant of gamma-glutamyl carboxylase causes des-gamma-carboxy prothrombin production in hepatocellular carcinoma cell lines.

Authors:  Naoki Ueda; Hidenori Shiraha; Tatsuya Fujikawa; Nobuyuki Takaoka; Yutaka Nakanishi; Mayumi Suzuki; Noriyuki Matsuo; Shigetomi Tanaka; Shin-Ichi Nishina; Masayuki Uemura; Akinobu Takaki; Yasushi Shiratori; Kazuhide Yamamoto
Journal:  Mol Oncol       Date:  2008-06-20       Impact factor: 6.603

3.  A Novel LC-MS/MS Assay for Quantification of Des-carboxy Prothrombin and Characterization of Warfarin-Induced Changes.

Authors:  Abdul Basit; Bhagwat Prasad; Joanne K Estergreen; Daniel E Sabath; Nathan Alade; David L Veenstra; Allan E Rettie; Kenneth E Thummel
Journal:  Clin Transl Sci       Date:  2020-03-09       Impact factor: 4.689

4.  Inclusive Quantification Assay of Serum Des-γ-Carboxyprothrombin Proteoforms for Hepatocellular Carcinoma Surveillance by Targeted Mass Spectrometry.

Authors:  Jihyeon Lee; Young-Suk Lim; Jeong-Hoon Lee; Geum-Youn Gwak; Misol Do; Injoon Yeo; Dongyoon Shin; Dohyun Han; Taesung Park; Youngsoo Kim
Journal:  Hepatol Commun       Date:  2021-06-12

Review 5.  Progression of Prothrombin Induced by Vitamin K Absence-II in Hepatocellular Carcinoma.

Authors:  Yang Yang; Guangbing Li; Ziwen Lu; Yong Liu; Junjie Kong; Jun Liu
Journal:  Front Oncol       Date:  2021-11-10       Impact factor: 6.244

6.  Utility of serum des-gamma-carboxyprothrombin in the diagnosis of hepatocellular carcinoma among Nigerians, a case-control study.

Authors:  Akpakip I Ette; Dennis A Ndububa; Olusegun Adekanle; Udeme Ekrikpo
Journal:  BMC Gastroenterol       Date:  2015-09-04       Impact factor: 3.067

7.  Low dose compared to variable dose Warfarin and to Fondaparinux as prophylaxis for thromboembolism after elective hip or knee replacement surgery; a randomized, prospective study.

Authors:  Murray M Bern; Diane Hazel; Elizabeth Deeran; John R Richmond; Daniel M Ward; Damon J Spitz; David A Mattingly; James V Bono; Ronna H Berezin; Laura Hou; Gerald B Miley; Benjamin E Bierbaum
Journal:  Thromb J       Date:  2015-10-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.